CD274 and neoplasm: In the KEYNOTE-224 trial, PD-L1 expression calculated by the combined positive score (CPS, cutoff = 1) was found to be associated with improved ORR and PFS in responders (CR/PR), whereas PD-L1 expression calculated by the tumor proportion score (TPS, cutoff = 1%) has no predictive value as CPS (8).